0001534969-24-000073.txt : 20240328 0001534969-24-000073.hdr.sgml : 20240328 20240328175640 ACCESSION NUMBER: 0001534969-24-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240327 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boniface John J. CENTRAL INDEX KEY: 0001870674 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40606 FILM NUMBER: 24800928 MAIL ADDRESS: STREET 1: C/O SERA PROGNOSTICS, INC. STREET 2: 2749 EAST PARLEYS WAY, SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SERA PROGNOSTICS, INC. CENTRAL INDEX KEY: 0001534969 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 261911522 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2749 E. PARLEYS WAY STREET 2: SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 BUSINESS PHONE: (801) 990-0520 MAIL ADDRESS: STREET 1: 2749 E. PARLEYS WAY STREET 2: SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 4 1 wk-form4_1711662978.xml FORM 4 X0508 4 2024-03-27 0 0001534969 SERA PROGNOSTICS, INC. SERA 0001870674 Boniface John J. C/O SERA PROGNOSTICS, INC. 2749 EAST PARLEYS WAY, SUITE 200 SALT LAKE CITY UT 84109 0 1 0 0 Chief Scientific Officer 1 Class A Common Stock 2024-03-27 4 S 0 3753 9.62 D 139771 D Class A Common Stock 2024-03-27 4 M 0 48909 0.91 A 188680 D Class A Common Stock 2024-03-27 4 S 0 48909 9.62 D 139771 D Class A Common Stock 2024-03-28 4 M 0 24474 0.91 A 164245 D Class A Common Stock 2024-03-28 4 S 0 24474 9.04 D 139771 D Stock Option (right to buy) 0.91 2024-03-27 4 M 0 48909 0 D 2024-12-29 Class A Common Stock 48909 24474 D Stock Option (right to buy) 0.91 2024-03-28 4 M 0 24474 0 D 2024-12-29 Class A Common Stock 24474 0 D The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $9.24, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. The shares subject to this option are fully vested and exercisable. /s/ Benjamin G. Jackson, Attorney-in-fact 2024-03-28